ATE134643T1 - Verfahren zur herstellung von zidovudine - Google Patents

Verfahren zur herstellung von zidovudine

Info

Publication number
ATE134643T1
ATE134643T1 AT92914161T AT92914161T ATE134643T1 AT E134643 T1 ATE134643 T1 AT E134643T1 AT 92914161 T AT92914161 T AT 92914161T AT 92914161 T AT92914161 T AT 92914161T AT E134643 T1 ATE134643 T1 AT E134643T1
Authority
AT
Austria
Prior art keywords
zidovudine
producing
azt
complex
deoxythymidine
Prior art date
Application number
AT92914161T
Other languages
English (en)
Inventor
Bruno Konrad Radatus
Khashayar Karimian
Original Assignee
Acic Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acic Canada Inc filed Critical Acic Canada Inc
Application granted granted Critical
Publication of ATE134643T1 publication Critical patent/ATE134643T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT92914161T 1991-06-21 1992-06-22 Verfahren zur herstellung von zidovudine ATE134643T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71783191A 1991-06-21 1991-06-21

Publications (1)

Publication Number Publication Date
ATE134643T1 true ATE134643T1 (de) 1996-03-15

Family

ID=24883679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92914161T ATE134643T1 (de) 1991-06-21 1992-06-22 Verfahren zur herstellung von zidovudine

Country Status (9)

Country Link
US (2) US5387677A (de)
EP (1) EP0550714B1 (de)
AT (1) ATE134643T1 (de)
AU (1) AU2181592A (de)
CA (1) CA2090026C (de)
DE (2) DE69208636T2 (de)
ES (1) ES2085023T3 (de)
HU (1) HUT63852A (de)
WO (1) WO1993000351A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2111970C1 (ru) * 1996-06-25 1998-05-27 Иван Игоревич Федоров 3'-оксимино-2',3'-дидезоксинуклеозиды
RU2392969C1 (ru) * 2008-11-18 2010-06-27 Общество с ограниченной ответственностью "Базис" Способ получения биоцидного средства
CN102731600B (zh) * 2012-03-13 2013-06-19 绿洲生物技术(南通)有限公司 齐多夫定及其中间体的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
US4874751A (en) * 1985-03-16 1989-10-17 Burroughs Wellcome Co. Antibacterial treatment
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US4818750A (en) * 1985-09-17 1989-04-04 Burroughs Wellcome Co. Treatment of human viral infections
US4847244A (en) * 1985-09-17 1989-07-11 Burroughs Wellcome Co. Treatment of human viral infections
US4857511A (en) * 1985-09-17 1989-08-15 Burroughs Wellcome Co. Treatment of human viral infections
DE3650741T2 (de) * 1985-09-17 2000-10-12 The Wellcome Foundation Ltd., Greenford Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds
US4904770A (en) * 1988-03-24 1990-02-27 Bristol-Myers Company Production of 2',3'-dideoxy-2',3'-didehydronucleosides
US4921950A (en) * 1988-06-09 1990-05-01 Burroughs Wellcome Co. Preparation of 3'azido-3-'-deoxythymidine
US4916218A (en) * 1988-06-09 1990-04-10 Almond Merrick R 1-(β-D-xylofuranosyl)thymine derivatives

Also Published As

Publication number Publication date
US5387677A (en) 1995-02-07
WO1993000351A1 (en) 1993-01-07
AU2181592A (en) 1993-01-25
DE69208636T2 (de) 1996-07-11
US5519129A (en) 1996-05-21
DE550714T1 (de) 1995-06-14
EP0550714B1 (de) 1996-02-28
ES2085023T3 (es) 1996-05-16
HU9300462D0 (en) 1993-05-28
CA2090026A1 (en) 1992-12-22
HUT63852A (en) 1993-10-28
DE69208636D1 (de) 1996-04-04
EP0550714A1 (de) 1993-07-14
CA2090026C (en) 1995-09-19

Similar Documents

Publication Publication Date Title
DE69415736D1 (de) Verfahren zur herstellung von reinem wasser
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
DE69620461D1 (de) Verfahren zur herstellung von 1,1,1,3,3,-pentafluoropropanen
DE69618476D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69607344D1 (de) Verfahren zur herstellung von n,n'-disubstituierten cyclischen harnstoffen
ATE174601T1 (de) Verfahren zur herstellung von bisnoraldehyden aus bisnoralkohol
DE68905831D1 (de) Verfahren zur synthese von 3'-azido-3'-deoxythymidin und analoge.
DE69425496D1 (de) Verfahren zur herstellung von 1,4-dienen
DE69208636D1 (de) Verfahren zur herstellung von zidovudine
DE3860105D1 (de) Verfahren zur herstellung von 4,4'-dichlordiphenylsulfonen.
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
ATA41091A (de) Verfahren zur herstellung von beta-(d)-2',3'-didesoxyinosin
DE3578879D1 (de) Verfahren zur herstellung von 1,3-dimethyl-2-imidazolidinon.
DE69603261D1 (de) Verfahren zur herstellung von 1,2-benzisothiazolonen
DE59200623D1 (de) Verfahren zur Herstellung von Chromleder.
ATE147749T1 (de) Verfahren zur herstellung von azt(3'-azido-3'- desoxythymidin) und diebezüglichen verbindungen
DE69314480D1 (de) Verfahren zur herstellung von 1,1,1,2,2,4,4,5,5,5,-decafluorpentan
DE59401800D1 (de) Verfahren zur Herstellung von 1,1'-Binaphthylen
DE58904175D1 (de) Verfahren zur herstellung von 4,4'-dihalogeno-biphenylen.
DE69211838D1 (de) Verfahren zur herstellung von 1,1,1,2-tetrafluorethan
ATE241619T1 (de) Verfahren zur herstellung von nukleosid-analogen
DE59206245D1 (de) Verfahren zur herstellung von 3'-aminopropyl-2-sulfatoethylsulfon
ATE138927T1 (de) Verfahren zur herstellung von desoxynukleosiden
DE3874496D1 (de) Verfahren zur herstellung von 4,4'-dibrombiphenyl.
DE59209522D1 (de) Verbessertes Verfahren zur Herstellung des Mononatriumsalzes von Riboflavin 5'-phosphat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties